1. Home
  2. OLP vs BBNX Comparison

OLP vs BBNX Comparison

Compare OLP & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Liberty Properties Inc.

OLP

One Liberty Properties Inc.

HOLD

Current Price

$25.33

Market Cap

511.7M

Sector

Real Estate

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$16.49

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLP
BBNX
Founded
1982
2015
Country
United States
United States
Employees
N/A
423
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
511.7M
493.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
OLP
BBNX
Price
$25.33
$16.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$26.75
$23.80
AVG Volume (30 Days)
79.8K
1.1M
Earning Date
05-05-2026
04-21-2026
Dividend Yield
7.88%
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$82,740,000.00
N/A
Revenue This Year
$11.98
$34.90
Revenue Next Year
$3.71
$34.63
P/E Ratio
$88.64
N/A
Revenue Growth
1.02
N/A
52 Week Low
$19.62
$8.80
52 Week High
$25.00
$32.71

Technical Indicators

Market Signals
Indicator
OLP
BBNX
Relative Strength Index (RSI) 64.24 65.40
Support Level $20.09 $16.02
Resistance Level N/A $32.52
Average True Range (ATR) 0.55 1.07
MACD 0.05 0.14
Stochastic Oscillator 93.25 83.89

Price Performance

Historical Comparison
OLP
BBNX

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: